M. Garbarg

8.4k total citations · 3 hit papers
106 papers, 6.9k citations indexed

About

M. Garbarg is a scholar working on Immunology, Molecular Biology and Sensory Systems. According to data from OpenAlex, M. Garbarg has authored 106 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Immunology, 77 papers in Molecular Biology and 26 papers in Sensory Systems. Recurrent topics in M. Garbarg's work include Mast cells and histamine (82 papers), Receptor Mechanisms and Signaling (49 papers) and Olfactory and Sensory Function Studies (26 papers). M. Garbarg is often cited by papers focused on Mast cells and histamine (82 papers), Receptor Mechanisms and Signaling (49 papers) and Olfactory and Sensory Function Studies (26 papers). M. Garbarg collaborates with scholars based in France, Germany and United Kingdom. M. Garbarg's co-authors include Jean‐Charles Schwartz, Jean‐Michel Arrang, J.C. Schwartz, J.M. Arrang, H. Pollard, Martial Ruat, J.C. Schwartz, G. Barbin, Walter Schunack and M. Dam Trung Tuong and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

M. Garbarg

106 papers receiving 6.6k citations

Hit Papers

Auto-inhibition of brain histamine release mediated by a ... 1983 2026 1997 2011 1983 1991 1987 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Garbarg France 37 5.2k 4.1k 2.7k 1.0k 1.0k 106 6.9k
J.M. Arrang France 24 2.9k 0.6× 2.7k 0.7× 1.6k 0.6× 1.2k 1.2× 662 0.6× 51 4.7k
H. Pollard France 40 2.5k 0.5× 4.2k 1.0× 1.3k 0.5× 2.8k 2.7× 666 0.6× 88 7.0k
Patrizio Blandina Italy 39 1.9k 0.4× 2.1k 0.5× 1.2k 0.5× 1.1k 1.0× 736 0.7× 111 4.4k
Lindsay B. Hough United States 31 1.6k 0.3× 1.6k 0.4× 767 0.3× 1.1k 1.0× 337 0.3× 137 3.6k
J. Tardivel‐Lacombe France 21 1.1k 0.2× 1.7k 0.4× 594 0.2× 992 1.0× 317 0.3× 32 2.8k
Gerard B. Fox United States 39 926 0.2× 1.9k 0.5× 454 0.2× 1.1k 1.1× 227 0.2× 105 4.1k
Olga A. Sergeeva Germany 35 928 0.2× 1.1k 0.3× 778 0.3× 1.3k 1.2× 2.1k 2.1× 80 5.0k
Oliver Selbach Germany 19 640 0.1× 733 0.2× 439 0.2× 539 0.5× 790 0.8× 23 2.7k
Mark R. Brann United States 49 359 0.1× 7.8k 1.9× 207 0.1× 6.4k 6.1× 449 0.4× 112 10.3k
Curt Mazur United States 22 393 0.1× 2.0k 0.5× 217 0.1× 819 0.8× 165 0.2× 45 3.4k

Countries citing papers authored by M. Garbarg

Since Specialization
Citations

This map shows the geographic impact of M. Garbarg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Garbarg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Garbarg more than expected).

Fields of papers citing papers by M. Garbarg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Garbarg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Garbarg. The network helps show where M. Garbarg may publish in the future.

Co-authorship network of co-authors of M. Garbarg

This figure shows the co-authorship network connecting the top 25 collaborators of M. Garbarg. A scholar is included among the top collaborators of M. Garbarg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Garbarg. M. Garbarg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stark, Holger, Michael Krause, A. Rouleau, et al.. (2001). Enzyme-catalyzed prodrug approaches for the histamine H3-receptor agonist (R)-α-methylhistamine. Bioorganic & Medicinal Chemistry. 9(1). 191–198. 11 indexed citations
2.
Dimitriadou, Violetta, A. Rouleau, M. Dam Trung Tuong, et al.. (1997). Functional relationships between sensory nerve fibers and mast cells of dura mater in normal and inflammatory conditions. Neuroscience. 77(3). 829–839. 99 indexed citations
3.
Garbarg, M., et al.. (1996). Modulation of Pentagastrin-Induced Histamine Release by Histamine H3Receptors in the Dog. Scandinavian Journal of Gastroenterology. 31(7). 631–638. 19 indexed citations
4.
Dimitriadou, Violetta, A. Rouleau, M. Dam Trung Tuong, et al.. (1996). Rat cerebral mast cells undergo phenotypic changes during development. Developmental Brain Research. 97(1). 29–41. 25 indexed citations
5.
Krause, Michael, A. Rouleau, Holger Stark, et al.. (1996). New Potent Azomethine Prodrugs of the Histamine H3‐Receptor Agonist (R)‐α‐Methylhistamine Containing a Heteroarylphenyl Partial Structure. Archiv der Pharmazie. 329(4). 209–215. 4 indexed citations
6.
Krause, Michael, A. Rouleau, Holger Stark, et al.. (1995). Synthesis, X-ray Crystallography, and Pharmacokinetics of Novel Azomethine Prodrugs of (R)-.alpha.-Methylhistamine: Highly Potent and Selective Histamine H3 Receptor Agonists. Journal of Medicinal Chemistry. 38(20). 4070–4079. 40 indexed citations
7.
Ganellin, C. Robin, et al.. (1995). Design of Potent Non-Thiourea H3-Receptor Histamine Antagonists. Journal of Medicinal Chemistry. 38(17). 3342–3350. 31 indexed citations
8.
Elz, Sigurd, et al.. (1995). Synthesis and Histamine H1 Receptor Agonist Activity of a Series of 2-Phenylhistamines, 2-Heteroarylhistamines, and Analogs. Journal of Medicinal Chemistry. 38(8). 1287–1294. 64 indexed citations
10.
Garbarg, M. & J.C. Schwartz. (1993). The histamine H3 receptor : pharmacology and potential therapeutic applications. Annales Françaises d Anesthésie et de Réanimation. 12(2). 114–115. 1 indexed citations
12.
Schwartz, J.C., J.M. Arrang, M. Garbarg, H. Pollard, & Martial Ruat. (1991). Histaminergic transmission in the mammalian brain. Physiological Reviews. 71(1). 1–51. 825 indexed citations breakdown →
13.
Schwartz, J.C., J.M. Arrang, M. Garbarg, & H. Pollard. (1990). A third histamine receptor subtype: Characterisation, localisation and functions of the H3-receptor. Inflammation Research. 30(1-2). 13–23. 87 indexed citations
14.
Schwartz, Jean‐Charles, et al.. (1990). Modulation of Histamine Synthesis and Release in Brain via Presynaptic Autoreceptors and Heteroreceptors. Annals of the New York Academy of Sciences. 604(1). 40–54. 15 indexed citations
15.
Arrang, J.M., M. Garbarg, J Lecomte, et al.. (1989). The Third Histamine Receptor. International Archives of Allergy and Immunology. 88(1-2). 79–81. 11 indexed citations
16.
Garbarg, M., H. Pollard, M. Dam Trung Tuong, J.C. Schwartz, & Claude P. Gros. (1989). Sensitive Radioimmunoassays for Histamine and tele‐Methylhistamine in the Brain. Journal of Neurochemistry. 53(6). 1724–1730. 46 indexed citations
17.
Schwartz, J.C., J.M. Arrang, M. Garbarg, & H. Pollard. (1989). Histamine H3 Receptors in the Brain: Potent and Selective Ligands. PubMed. 7. 10–19. 1 indexed citations
18.
Garbarg, M. & J.C. Schwartz. (1988). Synergism between histamine H1- and H2-receptors in the cAMP response in guinea pig brain slices: effects of phorbol esters and calcium.. Molecular Pharmacology. 33(1). 38–43. 48 indexed citations
19.
Arrang, Jean‐Michel, M. Garbarg, & Jean‐Charles Schwartz. (1983). Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature. 302(5911). 832–837. 1323 indexed citations breakdown →
20.
Garbarg, M., et al.. (1978). Pharmacological characterization of histamine receptors mediating the stimulation of cyclic AMP accumulation in slices from guinea-pig hippocampus.. Molecular Pharmacology. 14(6). 971–982. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026